Jan 27 (Reuters) - Innate Immunotherapeutics Ltd IIL.AX :
* Responds to ASX price query
* Company is not aware of any information concerning it that would, if known by some in market, explain recent trading in its securities
* In recent weeks there have been a number of media articles in USA that may have brought co to attention of new U.S. Investors
* Company believes that it is in compliance with ASX listing rule 3.1 Source text for Eikon: Further company coverage: IIL.AX